Use access key #2 to skip to page content.
$42.40 -1.87 (-4.22%)
10/6/2008 4:02 PM

AstraZeneca plc (ADR) (AZN)

CAPS Rating:
****

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

View All Commentary (AZN)

Recs

0

Avatar mimosapartners (< 20) Submitted: 9/23/07 2:13 PM : Underperform Start Price: $47.26 AZN Score: -21.01

Several state AG's; Arkansas for one, have joined in a class action lawsuit that may prove costly for AZN.

Report this Post Replies: 0 | Reply

Featured Broker Partners